Literature DB >> 24001365

The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Peter D Walzer1.   

Abstract

I am honored to receive the second Lifetime Achievement Award by International Workshops on Opportunistic Protists and to give this lecture. My research involves Pneumocystis, an opportunistic pulmonary fungus that is a major cause of pneumonia ("PcP") in the immunocompromised host. I decided to focus on Pneumocystis ecology here because it has not attracted much interest. Pneumocystis infection is acquired by inhalation, and the cyst stage appears to be the infective form. Several fungal lung infections, such as coccidiomycosis, are not communicable, but occur by inhaling < 5 μm spores from environmental sources (buildings, parks), and can be affected by environmental factors. PcP risk factors include environmental constituents (temperature, humidity, SO2 , CO) and outdoor activities (camping). Clusters of PcP have occurred, but no environmental source has been found. Pneumocystis is communicable and outbreaks of PcP, especially in renal transplant patients, are an ongoing problem. Recent evidence suggests that most viable Pneumocystis organisms detected in the air are confined to a patient's room. Further efforts are needed to define the risk of Pneumocystis transmission in health care facilities; to develop more robust preventive measures; and to characterize the effects of climatological and air pollutant factors on Pneumocystis transmission in animal models similar to those used for respiratory viruses.
© 2013 The Author(s) Journal of Eukaryotic Microbiology © 2013 International Society of Protistologists.

Entities:  

Keywords:  Air pollution; climate; contagion; fungi; reflections

Mesh:

Year:  2013        PMID: 24001365      PMCID: PMC4578696          DOI: 10.1111/jeu.12072

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  90 in total

Review 1.  How contagious are common respiratory tract infections?

Authors:  Daniel M Musher
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia.

Authors:  N Lubis; D Baylis; A Short; J Stebbing; A Teague; S Portsmouth; M Bower; M Nelson; B Gazzard
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

3.  Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants.

Authors:  S L Vargas; W T Hughes; M E Santolaya; A V Ulloa; C A Ponce; C E Cabrera; F Cumsille; F Gigliotti
Journal:  Clin Infect Dis       Date:  2001-03-09       Impact factor: 9.079

4.  Activation and transmission in rats of infection with Pneumocystis.

Authors:  J O Hendley; T H Weller
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

5.  Pneumocystis carinii pneumonia. Studies on the diagnosis and treatment.

Authors:  D Rifkind; T D Faris; R B Hill
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

6.  Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs.

Authors:  C R Icenhour; S L Rebholz; M S Collins; M T Cushion
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication.

Authors:  M Chabé; E Dei-Cas; C Creusy; L Fleurisse; N Respaldiza; D Camus; I Durand-Joly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267

8.  Climatic factors and Pneumocystis jiroveci infection in southern Spain.

Authors:  J M Varela; C Regordán; F J Medrano; N Respaldiza; C de La Horra; M A Montes-Cano; E J Calderón
Journal:  Clin Microbiol Infect       Date:  2004-08       Impact factor: 8.067

9.  Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response.

Authors:  Chun Li An; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci.

Authors:  Kieran R Daly; Judy Koch; Linda Levin; Peter D Walzer
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

View more
  4 in total

Review 1.  Evolution of the human pathogenic lifestyle in fungi.

Authors:  Antonis Rokas
Journal:  Nat Microbiol       Date:  2022-05-04       Impact factor: 30.964

2.  Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.

Authors:  Jonathan J Juliano; Eric Barnett; Christian M Parobek; Steve M Taylor; Steven R Meshnick; Stephen Stone; Emily Chang; Serena Fong; Laurence Huang
Journal:  Open Forum Infect Dis       Date:  2015-06-03       Impact factor: 3.835

3.  Severe Pneumocystis jirovecii pneumonia in an idiopathic CD4+ lymphocytopenia patient: case report and review of the literature.

Authors:  Bernabé F F Chumpitazi; Pierre Flori; Jean-Baptiste Kern; Marie-Pierre Brenier-Pinchart; Sylvie Larrat; Clémence Minet; Laurence Bouillet; Danièle Maubon; Hervé Pelloux
Journal:  JMM Case Rep       Date:  2014-12-01

4.  Predicting Species Boundaries and Assessing Undescribed Diversity in Pneumocystis, an Obligate Lung Symbiont.

Authors:  Spenser J Babb-Biernacki; Jacob A Esselstyn; Vinson P Doyle
Journal:  J Fungi (Basel)       Date:  2022-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.